MapLight Therapeutics, Inc. (MPLT)
7.29
+0.36
(+5.19%)
USD |
NASDAQ |
Nov 09, 16:00
7.29
0.00 (0.00%)
After-Hours: 20:00
MapLight Therapeutics Total Return Level : 6.93 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 6.93 |
| November 05, 2026 | 6.22 |
| November 04, 2026 | 6.71 |
| November 03, 2026 | 6.81 |
| November 02, 2026 | 6.78 |
| October 30, 2026 | 7.58 |
| October 29, 2026 | 7.72 |
| October 28, 2026 | 7.98 |
| October 27, 2026 | 8.17 |
| October 26, 2026 | 7.66 |
| October 23, 2026 | 7.97 |
| October 22, 2026 | 8.25 |
| October 21, 2026 | 8.16 |
| October 20, 2026 | 8.24 |
| October 19, 2026 | 8.00 |
| October 16, 2026 | 7.70 |
| October 15, 2026 | 8.02 |
| October 14, 2026 | 7.81 |
| October 13, 2026 | 7.875 |
| October 12, 2026 | 8.60 |
| October 09, 2026 | 8.83 |
| October 08, 2026 | 9.15 |
| October 07, 2026 | 9.36 |
| October 06, 2026 | 9.69 |
| October 05, 2026 | 9.275 |
| Date | Value |
|---|---|
| October 02, 2026 | 9.82 |
| October 01, 2026 | 9.63 |
| September 30, 2026 | 10.19 |
| September 29, 2026 | 10.15 |
| September 28, 2026 | 10.45 |
| September 25, 2026 | 10.46 |
| September 24, 2026 | 10.76 |
| September 23, 2026 | 10.77 |
| September 22, 2026 | 10.86 |
| September 21, 2026 | 10.90 |
| September 18, 2026 | 10.92 |
| September 17, 2026 | 11.32 |
| September 16, 2026 | 11.40 |
| September 15, 2026 | 12.08 |
| September 14, 2026 | 13.15 |
| September 11, 2026 | 13.00 |
| September 10, 2026 | 13.78 |
| September 09, 2026 | 13.71 |
| September 08, 2026 | 13.95 |
| September 04, 2026 | 13.77 |
| September 03, 2026 | 13.14 |
| September 02, 2026 | 13.06 |
| September 01, 2026 | 13.31 |
| August 31, 2026 | 12.97 |
| August 28, 2026 | 12.60 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Cullinan Therapeutics, Inc. | 11.31 |
| Arrowhead Pharmaceuticals, Inc. | 58.16 |
| Oncolytics Biotech, Inc. | 0.4394 |
| Sangamo Therapeutics, Inc. | 0.114 |
| Sarepta Therapeutics, Inc. | 17.82 |